The invention relates to a liquid pharmaceutical composition comprising a pegylated IFN-&bgr; (PEG-IFN-&bgr;), an excipient, a surfactant and a buffer wherein said excipient is a polyol, wherein said surfactant is a non-ionic surfactant and wherein said buffer is a sodium acetate buffer.